blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2556826

EP2556826 - Modified-release multiparticulate formulation of diltiazem HCL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.07.2017
Database last updated on 16.07.2024
Most recent event   Tooltip19.06.2020Lapse of the patent in a contracting state
New state(s): HR		published on 22.07.2020  [2020/30]
Applicant(s)For all designated states
Valpharma S.p.A.
Via Ranco, 112
47899 Serravalle / SM
[2013/07]
Inventor(s)01 / Valducci, Roberto
Via del Sole 4
47039 Savignano sul Rubicone / IT
02 / Alighieri, Tiziano
Via Casadei Flavia, 24
47900 Rimini / IT
03 / Avanessian, Serozh
Via Cesare Pavese 34
47827 Villa Verucchio / IT
 [2013/07]
Representative(s)Valenza, Silvia, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [2013/07]Valenza, Silvia, et al
Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria 9
20122 Milano / IT
Application number, filing date12179426.706.08.2012
[2013/07]
Priority number, dateIT2011FI0017208.08.2011         Original published format: IT FI20110172
[2013/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2556826
Date:13.02.2013
Language:EN
[2013/07]
Type: B1 Patent specification 
No.:EP2556826
Date:21.09.2016
Language:EN
[2016/38]
Search report(s)(Supplementary) European search report - dispatched on:EP15.10.2012
ClassificationIPC:A61K9/50, A61K31/554
[2013/07]
CPC:
A61K31/554 (EP); A61K9/5047 (EP); A61K9/5073 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/38]
Former [2013/07]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Mehrteilchenformulierung von Diltiazem-HCL mit modifizierter Freisetzung[2013/07]
English:Modified-release multiparticulate formulation of diltiazem HCL[2013/07]
French:Formulation multiparticulaire à libération modifiée de diltiazem HCL[2013/07]
Examination procedure05.08.2013Amendment by applicant (claims and/or description)
05.08.2013Examination requested  [2013/37]
29.04.2016Communication of intention to grant the patent
29.07.2016Fee for grant paid
29.07.2016Fee for publishing/printing paid
29.07.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.04.2016
Opposition(s)22.06.2017No opposition filed within time limit [2017/35]
Fees paidRenewal fee
13.08.2014Renewal fee patent year 03
10.08.2015Renewal fee patent year 04
11.08.2016Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.08.2012
AL21.09.2016
AT21.09.2016
BE21.09.2016
CY21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
HR21.09.2016
LT21.09.2016
LV21.09.2016
MC21.09.2016
MK21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SI21.09.2016
SK21.09.2016
SM21.09.2016
TR21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
[2020/30]
Former [2020/15]HU06.08.2012
AL21.09.2016
AT21.09.2016
BE21.09.2016
CY21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
MC21.09.2016
MK21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SI21.09.2016
SK21.09.2016
SM21.09.2016
TR21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2019/51]HU06.08.2012
AL21.09.2016
AT21.09.2016
BE21.09.2016
CY21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
MC21.09.2016
MK21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SI21.09.2016
SK21.09.2016
SM21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2019/46]HU06.08.2012
AL21.09.2016
AT21.09.2016
BE21.09.2016
CY21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
MC21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SI21.09.2016
SK21.09.2016
SM21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2019/31]HU06.08.2012
AL21.09.2016
AT21.09.2016
BE21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
MC21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SI21.09.2016
SK21.09.2016
SM21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2018/47]AL21.09.2016
AT21.09.2016
BE21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
MC21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SI21.09.2016
SK21.09.2016
SM21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2018/18]AT21.09.2016
BE21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
MC21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SI21.09.2016
SK21.09.2016
SM21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2017/52]AT21.09.2016
BE21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SI21.09.2016
SK21.09.2016
SM21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2017/34]AT21.09.2016
BE21.09.2016
CZ21.09.2016
DK21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SK21.09.2016
SM21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2017/32]AT21.09.2016
BE21.09.2016
CZ21.09.2016
EE21.09.2016
FI21.09.2016
LT21.09.2016
LV21.09.2016
PL21.09.2016
RO21.09.2016
RS21.09.2016
SE21.09.2016
SK21.09.2016
SM21.09.2016
BG21.12.2016
NO21.12.2016
GR22.12.2016
IS21.01.2017
Former [2017/13]FI21.09.2016
LT21.09.2016
LV21.09.2016
RS21.09.2016
SE21.09.2016
NO21.12.2016
GR22.12.2016
Former [2017/11]FI21.09.2016
LT21.09.2016
RS21.09.2016
SE21.09.2016
NO21.12.2016
GR22.12.2016
Former [2017/10]FI21.09.2016
LT21.09.2016
RS21.09.2016
SE21.09.2016
NO21.12.2016
Former [2017/09]FI21.09.2016
LT21.09.2016
NO21.12.2016
Former [2017/07]LT21.09.2016
Documents cited:Search[IY]US5670172  (BUXTON IAN RICHARD [GB], et al) [I] 1-9 * the whole document * * example 1; claims 1,7-9; tables 1-4 * [Y] 1-9;
 [Y]EP1125586  (TANABE SEIYAKU CO [JP]) [Y] 1-9 * the whole document * * paragraphs [0052] - [0055]; example - *
by applicantUS5344657
 WO2005016317
 WO9723219
 US2003003149
 US7067151
 WO0004883
 WO9629992
 US5622716
 WO9300093
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.